The effect of treatment modifications by an onco-geriatric MDT on one-year mortality, days spent at home and postoperative complications

Shared decision-making in the Netherlands: Progress is made, but not for all. Time to become inclusive to patients

“…Four examples have in common that the implementation of SDM was evaluated on choices made and costs. Three of these examples led to significant changes in decisions made and/or cost reductions [37,39,40]. Such impact on decisions made and costs were not seen in the study in primary care, the only one with a robust design for evaluation [38].…”

“…Although patients in the intervention group reported more involvement in decisionmaking, no significant differences in any of the clinical outcomes were observed between intervention patients and controls during the follow-up. Improving SDM in oncological teams [39] oncological not involve patients with LHL to begin with [62], or misinterpret a passive role in the communication as disinterest [51]. At the same time, physicians often overestimate the health literacy of patients, use communication that is too complicated, and do not actively check whether the patient understands the information [63].…”

Multidisciplinary Approach to Older Adults with Hematologic Malignancies—a Paradigm Shift

“…Fortunately, oncogeriatric-specific multidisciplinary teams are increasingly utilized in evaluation of older adults with cancer. In a recent study, patients 70 years or older with solid tumor malignancy were reviewed at surgical oncology tumor board and in an oncogeriatric-specific multidisciplinary team after completing geriatric assessment [33]. The recommendation from the oncogeriatric multidisciplinary team led to treatment modification in 25% of patients with similar 1-year mortality between patients with modified versus unmodified treatment plan (26.1% vs. 29.7%, p = 0.7).…”

Biometric Monitoring Technologies in Cancer: The Past, Present, and Future

“…Identifying and managing deficits identified through the geriatric assessment may improve clinical outcomes. 29,30 Because patients may be functionally compromised by cancer or its treatment at a younger age, we recommend that the remote use of PROs and wearable sensors is evaluated for patients of all age groups. This would create a normative reference data set to define reference ranges for physical activity (along with well-defined variables) and other relevant parameters.…”